StockNews.com assumed coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a report issued on Tuesday. The brokerage issued a sell rating on the medical research company’s stock.
Organovo Stock Performance
Organovo stock opened at $0.43 on Tuesday. The stock’s 50 day moving average price is $0.44 and its 200 day moving average price is $0.45. The firm has a market capitalization of $7.35 million, a PE ratio of -0.50 and a beta of 0.45. Organovo has a one year low of $0.32 and a one year high of $1.83.
Organovo (NASDAQ:ONVO – Get Free Report) last announced its earnings results on Wednesday, February 19th. The medical research company reported ($0.19) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.21) by $0.02. Organovo had a negative return on equity of 346.26% and a negative net margin of 10,151.64%. The company had revenue of $0.02 million for the quarter, compared to analyst estimates of $0.05 million. On average, analysts forecast that Organovo will post -0.77 earnings per share for the current fiscal year.
About Organovo
Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.
Featured Stories
- Five stocks we like better than Organovo
- Growth Stocks: What They Are, Examples and How to Invest
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- The Basics of Support and Resistance
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- What does consumer price index measure?
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Organovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo and related companies with MarketBeat.com's FREE daily email newsletter.